Recent studies presented at ASCO and published in the International Journal of Gynecologic Cancer, evaluated the association between prediction of response to chemotherapy and progression-free interval and overall survival in ovarian cancer.
By : |
02-26-2010
|
Health and Fitness:Healthcare
| Total Views :
983